课题基金 / 基金详情

Expression of Inducible 6-phosphofructo-2-kinase Isoforms in Skeletal Muscle and Their Potential Role in Glycolytic Regulation

Expression of Inducible 6-phosphofructo-2-kinase Isoforms in Skeletal Muscle and Their Potential Role in Glycolytic Regulation
诱导型 6-磷酸果糖-2-激酶亚型在骨骼肌中的表达及其在糖酵解调节中的潜在作用
批准号:
18590971
负责人:
TOSHIYA Atsumi
金额:
$2.55万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
6-磷酸果糖-2-激酶/果糖- 2,6 -二磷酸酶(PFK-2/F2, 6BPase)是负责果糖- 2,6 -二磷酸(F2, 6BP)合成和降解的酶。F2, 6BP反过来是6-磷酸果糖-1激酶(PFK-1)的强效变构激活剂,PFK-1是糖酵解的限速酶。至少有4个基因编码PFK-2/FBPase (PFKFB1-4),由PFKFB3编码的诱导型PFK-2 (iPFK-2)已被发现介导脂肪细胞中F2, 6BP的产生,这表明iPFK-2在甘油三酯合成中的潜在作用。在本研究中,我们研究了iPFK-2/PFKFB3在骨骼肌中的作用。PFKFB3基因通过7外显子(A-G)的选择性剪接产生多个同种异构体。我们分析了小鼠骨骼肌中存在的剪接变体,并观察了PFKFB3-ACG、ACDG和AG三种变体的表达,其中PFKFB3-ACDG是主要表达形式。为了研究肌肉糖酵解刺激物LPS对PFKFB3 mRNA表达的影响,8周龄BALB/c小鼠腹腔注射LPS, 3小时后去肌,采用实时RT-PCR分析PFKFB3 mRNA的表达。LPS处理显著诱导了PFKFB3 mRNA的表达,且LPS处理小鼠剪接变异的表达模式与对照小鼠不同。转染编码PFKFB3不同剪接变体的质粒(PFKFB3- acct、PFKFB3- acdg或PFKFB3- ag)后,HEK293细胞内F2、6BP含量显著升高。这些数据与过量产生F2, 6BP在诱导代谢改变中的作用一致。此外,体内数据表明,刺激骨骼肌中的iPFK-2可能是治疗糖尿病的潜在靶点
英文摘要
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (PFK-2/F2, 6BPase) is the enzyme responsible for the synthesis and degradation of fructose-2, 6-bisphosphate (F2, 6BP). F2, 6BP in turn is a powerful allosteric activator of 6-phosphofructo-1-kinase (PFK-1), which is the rate-limiting enzyme for glycolysis. At least 4 genes encode PFK-2/FBPase (PFKFB1-4), and an inducible PFK-2 (iPFK-2), encoded by PFKFB3, has been discovered to mediate F2, 6BP production in adipocytes suggesting the potential role of iPFK-2 in triglyceride synthesis. In this study, we investigated the role of iPFK-2/PFKFB3 in skeletal muscle.The PFKFB3 gene generates multiple isoforms by the alternative splicing of 7 exon (A-G). We analyzed the splicing variants present in mouse skeletal muscle, and observed the expression of the three variants, PFKFB3-ACG, ACDG, and AG, with PFKFB3-ACDG being the dominantly expressed form. To investigate the effect of LPS, which is a stimulant of glycolysis in muscle, on the expression of PFKFB3 mRNA, eight-wk old BALB/c mice were injected intraperitoneally with LPS and three hours later the muscle was removed and the expression of PFKFB3 mRNA analyzed by real-time RT-PCR. A significant induction of PFKFB3 mRNA was observed after LPS treatment, and the expression pattern of splicing variants in LPS treated mice was different from that of control mice. HEK293 cells stably transfected with plasmids encoding the different splice variants of PFKFB3 (PFKFB3-ACCT, PFKFB3-ACDG or PFKFB3-AG) showed a marked elevation in intracellular F2, 6BP content.These data are consistent with a role for the overproduction of F2, 6BP in the induction of metabolic alteration. Moreover, the in vivo data suggest that the stimulation of iPFK-2 in skeletal muscle may be a potential target for the treatment of diabetes
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
糖尿病の病態と解糖系の分子機構、糖尿病学の進歩 第41集
糖尿病病理学和糖酵解的分子机制,糖尿病科学进展第 41 卷。
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [SakoY,Usuki F, Suga H, 塚本 和久, Agents for Dyslipidemia(高脂血症治療薬), 石木学, Manabu Ishiki, Okamoto T, Atsumi T, Atsumi T, Atsumi T, Atumi T, Okamoto T, Atsumi T, Niwa H, Niwa H, 渥美 敏也]
通讯作者: 渥美 敏也
DOI: 10.5551/jat.e495
发表时间: 2008-02-01
期刊: JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
影响因子: 4.4
作者: [Okamoto, Toshiya, Atsumi, Toshiya, Koike, Takao]
通讯作者: Koike, Takao
DOI: 10.1507/endocrj.k06-205
发表时间: 2007-08
期刊: Endocrine journal
影响因子: 2
作者: [T. Atsumi;H. Chiba;N. Yoshioka;R. Bucala;T. Koike]
通讯作者: T. Atsumi;H. Chiba;N. Yoshioka;R. Bucala;T. Koike
糖尿病学の進歩2007
2007 年糖尿病学进展
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [SakoY,Usuki F, Suga H, 塚本 和久, Agents for Dyslipidemia(高脂血症治療薬), 石木学, Manabu Ishiki, Okamoto T, Atsumi T, Atsumi T, Atsumi T, Atumi T, Okamoto T, Atsumi T, Niwa H, Niwa H, 渥美 敏也, 渥美敏也]
通讯作者: 渥美敏也
6
    国内基金
    海外基金
    糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
    • 批准号:
      82371634
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      赵福军
    • 依托单位:
    LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
    • 批准号:
      82371213
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      王修哲
    • 依托单位:
    DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
    • 批准号:
      82370719
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      曹爱丽
    • 依托单位:
    低剂量辐射通过CXCR4途径介导糖尿病大鼠内皮祖细胞的归巢机制
    • 批准号:
      81300660
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      郭蔚莹
    • 依托单位: